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ABSTRACT
In response to injury, skeletal muscle stem cells (MuSCs) undergo
myogenesis where they become activated, proliferate rapidly,
differentiate and undergo fusion to form multinucleated myotubes.
Dramatic changes in cell size, shape, metabolism and motility occur
during myogenesis, which cause cellular stress and alter proteostasis.
The molecular chaperone heat shock protein 70 (HSP70) maintains
proteostasis by regulating protein biosynthesis and folding, facilitating
transport of polypeptides across intracellular membranes and
preventing stress-induced protein unfolding/aggregation. Although
HSP70 overexpression can exert beneficial effects in skeletal muscle
diseases and enhance skeletal muscle repair after injury, its effect
on myogenesis has not been investigated. Plasmid-mediated
overexpression of HSP70 did not affect the rate of C2C12 proliferation
or differentiation, but the median number of myonuclei per myotube and
medianmyotubewidth in differentiatedC2C12myotubeswere increased
withHSP70overexpression. These findings reveal that increasedHSP70
expression can promote myoblast fusion, identifying a mechanism for its
therapeutic potential to enhance muscle repair after injury.
This article has an associated First Person interview with the first author
of the paper.
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INTRODUCTION
Skeletal muscle has a remarkable ability to regenerate in response to
injury due to its resident population of adult muscle stem cells
(MuSCs). Following injury, MuSCs are activated, enter the cell
cycle and become specified to the myogenic lineage after which
they proliferate rapidly, differentiate and ultimately undergo fusion
and maturation (Yin et al., 2013). During myogenesis, dramatic
changes occur in cell size, shape, metabolism, and motility, which
alter proteostasis and cause cellular stress (Tang and Rando, 2014).
Stressed cells produce heat shock proteins (HSPs) as an adaptive
mechanism to survive the insult. Heat shock protein 70 (HSP70),
the most well studied member of the highly conserved HSP family
of molecular chaperones, protects against cellular stress and
maintains proteostasis (Clerico et al., 2015; Thakur et al., 2018).
Transgenic manipulation of HSP70 and pharmacological
induction of Hsp72 (the inducible form of HSP70) have beneficial
effects in muscle conditions including ageing, diabetes, obesity,
disuse atrophy and Duchenne muscular dystrophy (Chung et al.,
2008; Drew et al., 2014; Gehrig et al., 2012; Henstridge et al., 2014;
Kennedy et al., 2016; McArdle et al., 2004; Senf et al., 2008).
Furthermore, studies in HSP70−/− mice identified an important role
for extracellular HSP70 in muscle repair through regulating the innate
immune response and the activity of endogenousMuSCs at the site of
damage (Senf et al., 2013). While HSP70 has well-established roles
in regulating stress in skeletal muscle, comparatively little is known of
its role in myogenesis (Liu et al., 2006; Senf et al., 2013).
HSP70 expression has been detected in slow type I fibres in mouse
soleus and plantaris muscles at embryonic day 22 (Ogata et al., 2003),
and muscle fibres in mice with a systemic deletion of HSP70 have a
reduced cross-sectional area (Senf et al., 2013). In addition, whole
transcriptome analyses of quiescent and activated MuSCs and
proliferating and differentiating muscle cells revealed differential
expression of the genes encodingHSP70 (Liu et al., 2013; Ryall et al.,
2015).More recently, studies in C2C12 cells have identified a role for
HSP70 in myoblast differentiation via stabilisation of p38MAPK
(Fan et al., 2018).We and others have found that protein expression of
HSP70 increases during the early stages of differentiation relative to
that in proliferating myoblasts (Fan et al., 2018; Thakur et al., 2019),
peaking at the onset of myoblast fusion, but the consequences of
increased HSP70 expression during myogenesis have not been
determined. Here we have overexpressed a GFP-HSP70 fusion
protein in C2C12 myoblasts and investigated effects on proliferation,
differentiation and fusion.
RESULTS
GFP-HSP70 overexpression does not alter subcellular
localisation of HSP70
Before assessing the effect of HSP70 overexpression on myoblast
functions, we first confirmed expression and subcellular localisation
of the GFP-HSP70 fusion protein. C2C12 cells were either left
untransfected (control), or transfected with GFP or GFP-HSP70,
incubated for 24 h, then lysed for protein extraction. Western
immunoblotting of C2C12 cell lysates probed with HSP70
antibody confirmed the presence of a 99 kDa band corresponding
to GFP-HSP70 (Fig. 1A). No GFP-HSP70 was detected in either
untransfected (CON) or GFP-transfected cells. Endogenous HSP70
(72 kDa) was expressed at similar levels across all groups (Fig. 1A).
We next examined the subcellular localisation of HSP70 in control
(Fig. 1B), GFP-transfected (Fig. 1C), and GFP-HSP70-transfected
(Fig. 1D) C2C12 myoblasts under control conditions and in response
to heat shock for 2 h at 42°C. Endogenous HSP70/72 localisedReceived 26 May 2020; Accepted 17 June 2020
Centre for Muscle Research, Department of Physiology, University of Melbourne,
Victoria, Australia 3010.
*(deceased) With much sadness we report that talented research scholar Savant
Thakur died on June 16, 2019 as a result of complications arising from Duchenne
muscular dystrophy
‡
Author for correspondence (gsl@unimelb.edu.au)
J.L.J., 0000-0001-5710-866X; G.S.L., 0000-0001-9220-9810
This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
distribution and reproduction in any medium provided that the original work is properly attributed.
1









diffusely throughout the cytoplasm and the nucleus of both control
(Fig. 1B; top) and GFP-transfected (Fig. 1C; top) cells, and
translocated to the nucleus after heat shock (Fig. 1B,C; bottom). In
GFP-transfected C2C12 myoblasts, GFP was localised throughout
the cytoplasm and nucleus and its localisation did not change after
heat shock (Fig. 1C). In GFP-HSP70-transfected cells, the GFP-
HSP70 transgene was present mainly in the cytoplasm under control
conditions (Fig. 1D; top) but became concentrated in the nucleus after
heat shock, similar to endogenous HSP70/72 (Fig. 1D; bottom).
Together, these data demonstrate that the GFP-HSP70 fusion protein
is expressed in transfected C2C12 cells and retains the ability of
endogenous HSP70 to translocate to the nucleus after heat shock.
GFP-HSP70 overexpression does not alter the rate of C2C12
cell proliferation or differentiation
To determine whether HSP70 overexpression alters C2C12 cell
proliferation, cells were seeded at a low density and raw cell counts
were taken at 24, 48 and 72 h post-transfection. Blue boxes
representing the number of GFP transfected cells and red triangles
representing GFP-HSP70 transfected cells overlapped almost
completely at each timepoint and the growth curves were identical
(Fig. 2A). No difference was observed in the mean doubling times
of C2C12 myoblasts transfected with either GFP or GFP-HSP70
(Fig. 2B). Therefore, HSP70 overexpression does not alter the
proliferative capacity of C2C12 myoblasts.
Fig. 1. Expression and subcellular
localisation of GFP-HSP70 in
C2C12 cells. Plasmid DNA encoding
either GFP or a GFP-HSP70 fusion
protein was transfected into
proliferating C2C12 cells and the
expression and localisation of each
protein was assessed. (A) Western
blot showing protein expression of
endogenous HSP70 and the GFP-
HSP70 fusion protein in control
C2C12 cells (CON; not transfected),
or cells transfected with plasmids
encoding GFP or GFP-HSP70. β-actin
is shown as the loading control.
Representative immunofluorescence
images of control C2C12 cells (B) or
cells transfected with GFP (C) or
GFP-HSP70 (D) in control conditions
(top row) or following 2 h of heat
shock at 42°C (+HS, bottom row).
Cells were stained with DAPI (blue)
and HSP70 (red), and display GFP/
GFP-HSP70 (green) signal. Exposure
times are indicated.
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The ability of C2C12 cells transfected with either GFP or GFP-
HSP70 to undergo differentiation was next assessed by western
immunoblotting. Expression of endogenous HSP70 in GFP-
transfected and GFP-HSP70 transfected cells was similar at D2,
D3 and D4 of differentiation (Fig. 2C,D). The GFP-HSP70 fusion
protein was detected in all GFP-HSP70 transfected cells resulting in
a 12-, 9-, and 6-fold overexpression of HSP70 at D2, D3, and D4 of
differentiation, respectively. At D4GFP-HSP70 overexpression was
decreased relative to D2 (Fig. 2C,D), consistent with previous
reports of HSP70 expression levels during C2C12 differentiation
Fig. 2. See next page for legend.
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(Fan et al., 2018; Thakur et al., 2019). Analysis of myogenin
(Fig. 2C,E) and sarcomeric myosin heavy chain (Fig. 2C,F) protein
expression showed an expected decrease in myogenin expression
and concomitant increase in sarcomeric myosin heavy chain at D3
and D4 of differentiation relative to D2. No differences were
detected in the expression of either myogenin (Fig. 2C,E) or
sarcomeric myosin heavy chain (Fig. 2C,F) between GFP-
transfected cells and GFP-HSP70-transfected cells.
To further examine the effect of HSP70 overexpression on early
differentiation, myogenin immunofluorescence at D1 of differentiation
was investigated. A similar proportion of GFP-transfected cells and
GFP-HSP70-transfected cells expressed myogenin at this timepoint
(Fig. 2G,H). In contrast to previous reports indicating HSP70 deletion
impairs myoblast differentiation (Fan et al., 2018), these results show
that HSP70 overexpression does not alter the ability of C2C12 cells to
differentiate or their rate of differentiation.
C2C12 cells transfected with GFP-HSP70 undergo enhanced
fusion during differentiation
As HSP70 overexpression had no impact on proliferation or
differentiation of C2C12 myoblasts, we next examined the effect on
myoblast fusion and myotube formation. C2C12 cells were
transfected with either GFP or GFP-HSP70 and differentiated for
2, 3, or 4 days after which the size and number of nuclei per
myotube was determined. The median width of myotubes was
increased in GFP-HSP70 transfected cells relative to GFP-
transfected cells at D3 (Fig. 3A,C) and D4 (Fig. 3A,D) but not
D2 (Fig. 3A,B) of differentiation. In addition, the median number of
nuclei per myotube was increased in GFP-HSP70 transfected cells
relative to GFP-transfected cells at D2 (Fig. 3A,E), D3 (Fig. 3A,F)
and D4 (Fig. 3A,G) of differentiation.
We next analysed the number of nuclei per myotube, which was
significantly reduced in GFP-HSP70-transfected myotubes
containing less than 50 myonuclei; significantly increased in
myotubes with 51–200 nuclei; and unchanged in myotubes with
more than 200 nuclei relative to GFP-transfected myotubes at D3
(Fig. 3I) and D4 (Fig. 3J) but not D2 (Fig. 3H) of differentiation.
Together, these findings indicate that HSP70 overexpression
enhances myoblast fusion to increase myotube size.
DISCUSSION
Evidence to date supports a positive influence for HSP70 on
myogenic differentiation, which is consistent with evidence from
other cell lineages in which HSP70 promotes differentiation of
neurons (Loones et al., 2000), erythroblasts (Ribeil et al., 2007), and
mesenchymal stem cells (Li et al., 2018). HSP70 expression is
higher in differentiated C2C12 myotubes relative to proliferating
C2C12 myoblasts (Xiao et al., 2011). In addition, HSP70 protein
levels are increased in the early stages of C2C12 cell differentiation
(Fan et al., 2018; Thakur et al., 2019) and knockdown of HSP70
impairs C2C12 differentiation (Fan et al., 2018). Here we have
shown, for the first time, that overexpression of GFP-HSP70
enhances C2C12 myoblast fusion to increase myotube size.
Reduced or loss of HSP70 expression has previously been shown
to impair myoblast differentiation, with knockdown in C2C12
myoblasts resulting in reduced myogenin and myosin heavy chain
expression (Fan et al., 2018), and absence of HSP70 during
embryonic myogenesis resulting in reduced muscle fibre cross-
sectional area in adult mice (Senf et al., 2013). Therefore, it might be
expected that HSP70 overexpression would enhance differentiation.
Importantly, HSP70 overexpression altered neither C2C12
proliferation nor early differentiation, indicating that endogenous
levels of HSP70 are sufficient for maximal differentiation. In
contrast, overexpression of HSP70 significantly increased the rate of
myoblast fusion. It could therefore be speculated that the previously
reported impairment in differentiation seen in C2C12 cells after
HSP70 knockdown (Fan et al., 2018) might be due to a failure of
fusion rather than a failure to initiate differentiation. In support of
this, the authors report the presence of fewer nuclei in myotubes
after HSP70 knockdown (Fan et al., 2018). Taken together, this
suggests HSP70 plays an important role as a regulator of myoblast
fusion.
While the mechanism underlying enhanced myoblast fusion after
HSP70 overexpression in C2C12 cells was not investigated here, it
is possible the previously identified HSP70-linked stabilisation of
p38MAPK (Fan et al., 2018) facilitates signalling that drives
myotube fusion. Inhibition of p38MAPK inhibits C2C12 myotube
formation in vitro (Wu et al., 2000), an effect that can be directly
attributed to a block of myotube fusion (Gardner et al., 2015), and
overexpression of p38MAPK rescues impaired differentiation after
HSP70 knockdown (Fan et al., 2018). In addition, HSP70 interacts
directly with p38MAPK (Gong et al., 2012), and overexpression of
HSP70 increases the half-life of the p38MAPK protein (Fan et al.,
2018). p38MAPK has been proposed to drive myogenic
differentiation via activation of MyoD, but this appears to be
independent of increased myogenin or myosin heavy chain
expression which did not change with HSP70 overexpression.
Furthermore, whether HSP70 and/or p38MAPK alter the expression
or activity of the fusogenic proteins (e.g. myomaker, myomerger)
remains unknown. Therefore, exactly how HSP70-mediated
stabilisation of p38MAPK promotes myoblast fusion remains to
be determined.
In conclusion, HSP70 overexpression in proliferating C2C12
cells increased myotubewidth and the median number of myonuclei
per myotube, suggesting an important role of HSP70 in driving
myoblast fusion during muscle differentiation. Enhanced myoblast
fusion through increased HSP70 expression supports its therapeutic




To examine the effect of HSP70 overexpression on C2C12 cell proliferation
and differentiation, the pEGFP-C3 plasmid containing the murine HSP70
cDNA was used [pCMV-EGFP-HSP70 (GFP-HSP70)] was a gift from Lois
Greene [Addgene plasmid #15215, http://n2t.net/addgene:15215; RRID:
Fig. 2. GFP-HSP70 overexpression does not alter the rate of C2C12 cell
proliferation or differentiation. Plasmid DNA encoding either GFP or a
GFP-HSP70 fusion protein were transfected into proliferating C2C12 cells
and the effect on proliferation and differentiation was assessed. (A) Total cell
counts at 24 h, 48 h and 72 h post-transfection were used to generate
exponential growth curves for the GFP and GFP-HSP70 groups. (B) Mean
doubling time (Td) was calculated from the exponential growth curves. Data
are presented as mean±s.e.m. for the cell counts and mean±95%
confidence interval for the doubling time; n=6 replicates/group/timepoint.
(C) Representative western blots and quantification of HSP70 (D), myogenin
(E), MyHC (F), relative to actin expression in C2C12 cells after 2, 3 and
4 days of differentiation. Data are presented as mean±s.e.m. and compared
with a two-way ANOVA and Tukey’s post-hoc test; n=3 replicates/group;
#P<0.05 versus GFP-HSP70 group; ^P<0.05 versus D2 GFP-HSP70.
(G) Representative immunofluorescence images of C2C12 cells transfected
with GFP (top row) or GFP-HSP70 (bottom row) and stained with MyoG at
D1. GFP+ MyoG+ cells are circled. (H) The proportion of GFP+ or GFP-
HSP70+ cells stained for MyoG was determined. Data are presented as
mean±s.e.m.; n=3 replicates/group.
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Fig. 3. See next page for legend.
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Addgene_15215; (Zeng et al., 2004)]. A plasmid vector encoding GFP
[pAAV-CMV-eGFP (GFP)], a kind gift from Professor Jeffrey S. Chamberlain
(Seattle, WA, USA), was used as control for overexpression experiments.
Cell culture
Proliferating C2C12 cells (American Type Culture Collection, ATCC,
Manassas, VA, USA) were cultured at 60–70% confluency in growth
media [Dulbecco’s Modified Eagle Medium (DMEM, 4.5 g/l D-glucose,
4.0 mM L-glutamine, no sodium pyruvate; Thermo Fisher Scientific,
Waltham, MA, USA) supplemented with 10% foetal bovine serum (FBS;
Thermo Fisher Scientific) and penicillin (100 units/ml)/streptomycin
(100 μg/ml) (Pen/strep; Thermo Fisher Scientific)]. Cells were maintained
in a humidified chamber at 37°C, in 95% air and 5% CO2. To induce
myogenic differentiation, C2C12 cells were grown to 100% confluency and
switched from growth media to low serum differentiation media [DMEM
supplemented with 2% horse serum (HS; Thermo Fisher Scientific) and pen/
strep]. Media was replaced with fresh differentiation media every 24 h.
Transient transfection of C2C12 cells
One to two hours after plating, C2C12 cells were transiently transfected with
plasmid DNA using Lipofectamine 3000 reagent (Thermo Fisher Scientific)
according to the manufacturer’s instructions. Briefly, DNA and
Lipofectamine were diluted separately in Opti-MEM (Thermo Fisher
Scientific). The diluted Lipofectamine was then added to DNA mixture and
allowed to complex for 5 min. The resulting DNA-lipid complexes were
added to the growth media and incubated for 20–22 h at 37°C in 5% CO2. To
confirm successful transfection with pAAV-CMV-eGFP and pEGFP-HSP70
plasmids, C2C12 cells were visualised under the GFP filter of Zeiss Primovert
light microscope (Carl Zeiss Pty. Ltd., Oberkochen, BadenWürttemberg,
Germany) and images were acquired with Axiocam ERc5s camera using Zen
software (Carl Zeiss Pty. Ltd.).
Cell proliferation assay
To analyse the rate of C2C12 cell proliferation, 2.0×104 cells were seeded
per well in 1.5 ml growth media onto six-well plates (Corning Costar cell
culture plates; Sigma-Aldrich, St Louis, MO, USA). Two hours after
seeding, cells were transfected with 1.0 μg of either GFP (n=6/timepoint) or
GFP-HSP70 (n=6/timepoint) plasmid DNA per well. The growth media was
refreshed 20 h post-transfection to remove excess transfection mix. Total
cell numbers were determined at 24, 48 and 72 h post-transfection using a
TC20 automated cell counter (Bio-Rad Laboratories, Hercules, CA, USA),
with each measurement performed in duplicate. An exponential growth
curve was generated from the cell counts and used to calculate the mean
doubling time (Td).
Direct and indirect fluorescence
For immunofluorescence analyses, 2×105 C2C12 cells were seeded per well
in 1 ml growth media in 12-well plates (Corning Costar cell culture plates;
Sigma-Aldrich) containing 18 mm round glass coverslips (Neuvitro,
Vancouver, WA, USA). Cells were transfected with 1 μg of GFP (n=3/
timepoint) or GFP-HSP70 (n=3/timepoint) plasmid DNA per well, 1 h post-
seeding. Once the cells reached 100% confluency, the growth media was
replaced with differentiation media to induce myogenic differentiation. The
cells were then allowed to differentiate for 1, 2, or 3 days with media changes
every 24 h. At 1, 2, or 3 days post-differentiation, cells were fixed with 4%
paraformaldehyde (PFA; Aesar, Ward Hill, MA, USA) in phosphate buffered
saline (PBS; Thermo Fisher Scientific) for 15 min, washed in PBS once and
then permeablised with 0.1% Triton X-100 (Sigma-Aldrich) in PBS for
10 min. Non-specific binding sites were blocked with 3% bovine serum
albumin (BSA, Sigma-Aldrich) in PBS for 45 min at room temperature.
Target proteins were detected by incubating coverslips in blocking solution
containing primary antibodies against mouse-α-myogenin IgG1 (1:200;
MA5-11486; Thermo Fisher Scientific) and mouse-α-sarcomeric myosin
heavy chain IgG2b [1:50; deposited to the University of Iowa Developmental
Studies HybridomaBank by Fischman, D.A. (DSHBHybridoma ProductMF
20)] at 4°C overnight. On the following day, coverslips were washed in PBS
(3×5 min) and incubated in blocking solution containing Alexa Fluor 555-
conjugated goat-α-mouse IgG1 (1:1000; A21127; Thermo Fisher Scientific)
and Alexa Fluor 555-conjugated goat-α-mouse IgG2b (1:1000; A21147;
Thermo Fisher Scientific) for 2 h at room temperature in the dark. The
coverslips were then washed with PBS (3×5 min) and counterstained with 4′
6-diamidino-2-phenylindole (DAPI; 1:1000, Thermo Fisher Scientific) in
PBS. Finally, coverslips were mounted onto glass slides using a water based
mounting medium (Fluoro-Gel; ProSciTech Pty. Ltd., Kirwan, QLD,
Australia) and coated in nail polish.
Immunofluorescence images were acquired on a Zeiss Axio Imager M2
microscope with a monochrome camera (AxioCam 506, Carl Zeiss Pty. Ltd.)
using Zen software (Carl Zeiss Pty. Ltd.). Images were taken for Texas red,
GFP andDAPI channels. Image analysis was performed using ImageJ software
(National Institute of Health, NIH, Bethesda, MD, USA). The number of GFP
or GFP-HSP70 transfected cells that stained positively for MyoGwere counted
for each field of the view at days 1 and 2 and expressed as a percentage of the
total number of GFP or GFP-HSP70+ cells. This proportion was used as an
index of the early differentiation rate. Myotube width was quantified at day 3
post-differentiation by calculating the mean of three measurements along each
the length of each GFP or GFP-HSP70+ myotube stained with MyHC. The
number ofmyonuclei present in each GFP or GFP-HSP70 transfectedmyotube
were also determined and used as index of cell fusion.
Western immunoblotting
Cells were washed twice in 2 ml PBS per well, PBS was aspirated from the
wells and intact six-well plates were stored at −80°C until the day of lysis
and protein extraction. Whole cell lysates were prepared as described
previously (Park et al., 2016). Briefly, cells were washed with ice-cold PBS
containing phenylmethylsulfonyl fluoride (PMSF, 1 mM, Thermo Fisher
Scientific) and subsequently lysed in ice-cold radioimmunoprecipitation
assay (RIPA) lysis buffer [50 mM TrisHCl (pH 7.4), 150 mM NaCl, 1 mM
EDTA, 1% Triton X-100, 1% Na-Deoxycholic acid and 0.1% sodium
dodecyl sulphate (SDS); Millipore, Billerica, MA, USA] containing
protease inhibitor cocktail (PIC, 1 mM, Sigma-Aldrich) using a cell
scraper (Corning Costar; Sigma-Aldrich). Cell lysates were sonicated for
15 s using a Microson XL-2000 sonicator (Misonix, NY, USA) to disrupt
the nuclear membrane, centrifuged for 10 min at 10,000 rpm and 4°C to
remove cellular debris, and stored at −80°C until further analysis. Total
protein concentration was determined through a DC protein assay (Bio-Rad
Laboratories) by measuring absorbance at 750 nm using a Multiskan
Spectrum spectrophotometer (Thermo Fisher Scientific). All samples were
equalised to a protein concentration of 1 μg/μl with RIPA lysis buffer.
Laemmli buffer [4×; 0.25 M TrisHCl (pH 6.8), 6% SDS, 40% glycerol,
0.04% bromophenol blue, 16% Dithiothreitol (DTT)] was then added and
samples were incubated for 5 min at 95°C. Identical amounts of each sample
(10 μg) were loaded onto pre-cast SDS-polyacrylamide gels (4–15%
Criterion TGX Stain-Free Precast Gels, Bio-Rad Laboratories) in Tris/
Glycine/SDS (TGS) buffer (Bio-Rad Laboratories) and resolved using
SDS-PAGE for 45 min at 200 V. Proteins were transferred onto
polyvinylidene difluoride (PVDF) membranes using a Trans-blot Turbo
Blotting System (Bio-Rad Laboratories) by applying a constant current
(1 amp) for 7 min. Efficient protein transfer was confirmed using post-
transfer stain free image of gel and membrane. Non-specific binding
sites were blocked by incubating the PVDF membrane in 3% BSA in
Tris-buffered saline containing Tween 20 (TBST; 50 mMTrisHCl, 150 mM
Fig. 3. GFP-HSP70 overexpression increases myotube nuclei number
and width. (A) C2C12 cells transfected with GFP or GFP-HSP70 were
differentiated for either 2 (D2), 3 (D3) or 4 (D4) days and stained with MyHC
(MF20). (A) Representative microscopic fields are shown and white-boxed
regions are shown at higher magnification. Myotube diameter was measured
at D2 (B), D3 (C) and D4 (D) of differentiation. The number of nuclei per
myotube was counted at D2 (E), D3 (F) and D4 (G) of differentiation. Data
are presented as 5th–95th percentile box and whisker plot and compared
with a Mann–Whitney test; n>100 myotubes were analysed; *P<0.05,
**P<0.01, ***P<0.001, ****P<0.0001 versus GFP. The proportion of
myotubes containing less than 50, between 51 and 200, or more than 200
nuclei was determined at D2 (H), D3 (I), and D4 (J) of differentiation. Data
are presented as mean±s.e.m. and compared with a two-way ANOVA and
Tukey’s post-hoc test; n>100 myotubes were analysed and averaged from
three independent experiments. *P<0.05, **P<0.01 versus GFP.
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NaCl, 0.05% Tween 20) for 2 h at room temperature. Target proteins were
detected by probing the PVDFmembranewith either rabbit-α-HSP70 (1:5000;
ADI-SPA-812, Enzo Life Science, Farmingdale, NY, USA), mouse-α-
myogenin (1:400; sc12732, Santa Cruz Biotechnology, Rockford, IL, USA),
mouse-α-MF20 (1:5000; DSHB Hybridoma Product MF 20), or rabbit-α-β-
actin (1:1000; Cell Signaling Technology, Danvers, MA, USA) diluted in 3%
BSA/TBSTovernight at 4°C. The following day, PVDFmembranewas washed
in TBST (1×2 min, 3×10 min) and incubated with 3% BSA/TBST containing
either HRP-sheep-α-mouse or HRP-donkey-α-rabbit IgG (1:5000; GE Life
Sciences, Buckinghamshire, UK) for 1 h at room temperature. PVDFmembrane
was then washed in TBST (1×2 min, 3×10 min) and immunodetection was
performed using SupersignalWest FemtoChemiluminescent Substrate (Thermo
Fisher Scientific). The membrane was visualised and imaged on a Chemidoc–
System (Bio-Rad Laboratories). The protein bands were analysed using
ImageLab software (Bio-Rad Laboratories) and the intensity band of interest
was normalised to total protein.
Statistical analysis
Data are presented as mean±s.e.m. unless indicated otherwise. Unpaired
Student’s t-test was used to compare differences between GFP and GFP-
HSP70 groups. When the assumption of Gaussian distribution was not met, a
non-parametric Mann–Whitney U-test was used for comparisons. For
comparisons between more than two groups, a one- or two-way ANOVA
was performed with a Tukey’s post-hoc test used when statistical differences
were detected. The level of significancewas set at P<0.05 for all comparisons.
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